lawpalyer logo
in判決書

智慧財產及商業法院97年度民專訴字第00005號

關鍵資訊

  • 裁判案由
    專利權損害賠償
  • 案件類型
    智財
  • 審判法院
    智慧財產及商業法院
  • 裁判日期
    97 年 10 月 28 日

  • 當事人
    日商武田藥品工業股份有限公司

9700005     Takeda Pharmaceutical Company Limited  Yas                    971014 尿PioglitazonePiog litazone Pioglitazone Hydrochloride尿Metformin Sulfonylurea尿 insulin 使135500尿906 7 105 6 111 3 8 9 使PioglitazoneMetformin 1013使PioglitazoneSulfonylureaPioglitazone 5-[4-[2-5--2- ] ]- 2,4- 5-[4 -[2-[5-1-- 2-] ] ]-2,4- Pioglitazone尿ACTOS 仿M-M-63119 827 1 101 4 104 5 M-M-561 使 PioglitazonePioglitazone HydrochlorideACTOS 仿使仿955 3 09516001590 951031951031d 仿仿921 1 WTO 4 2 仿15162228281 201 3 使 63119 135500827 21906 7 906 18仿尿957 12PioglitazonePioglitazone HydrochlorideGlitos仿仿仿使PioglitazoneSulfonylureaMetformin insulin 135500仿尿使尿PioglitazoneSulfonylureaMetformin insulin 使185 2 仿仿仿84881 881 841 185 2 PioglitazonePioglitazoneM-M-尿PioglitazonePioglitazone63119 使Pioglitazone尿使185 2 841 185 2 244 4 150 150 5%使仿仿Glitos仿使135500Pioglitazone Hydroch lorideSulfonylureaMetformin insulin 使Glitos 391 4 75394 201 1 3 7 12仿使仿仿仿仿201 3 仿仿仿仿仿 101 仿仿仿仿退仿09600252292 201 3 仿仿仿9613209 仿仿仿仿仿仿仿仿使150 使仿 仿仿1355001:0.00015 仿使135500調仿仿135500 63119 Pioglitazone21221 4 63119 PioglitazonePioglitazonePioglitazone63119 尿851889153 Pioglitazone63119 PioglitazonePioglitazone63119 135500尿906 7 105 6 11 63119 827 1 101 4 10 PioglitazonePioglitazone HydrochlorideACTOS 957 12GlitosPioglitazonePioglitazone Hydrochloride Pioglitazone仿仿仿 調 Pioglitazone63119 Pioglitazone63119 Pioglitazone Pioglitazone仿尿PioglitazoneSulfonylureaMetformin insulin 使135500185 2 Pioglitazone尿M-M-使63119 185 2 957 12PioglitazonePioglitazone H ydrochloride Glitos仿仿 135500尿906 7 105 6 1163119 827 1 101 4 10135500尿尿尿尿3 尿(A) (B) α- (Statin); (A) (B) 1:0.00015;33135500尿A ; A B ; A B 尿(A) / 尿( (A )) / 調PioglitazonePioglitazone HydrochlorideMetformin Sulfonylureainsulin Pioglitazone HydrochlorideACTOS 63119 211 161921I I 5-4-2-5--2- -2,4- M-I 5-4-2-5-1--2- -2,4- M-I 尿PioglitazonePioglitazone尿 PioglitazonePioglitazone Hy drochloride Metformin Sulfonylureainsulin Pioglitazone HydrochlorideACTOS PioglitazoneGeneric DrugPioglitazonePioglitazonePioglitazone Hydrochloride使Glitos仿尿PioglitazoneSulfonylureaMetformin insulin 使135500PioglitazonePioglitazoneHydrochloride http://drug.doh.gov.tw/medication_pubmed.php?type=pr&=pro http ://://www.nhi.gov.tw/inquire/query1.asp?menu=1&menuid=8enu_使使使Metformin Sulfonylurea尿insulin A B 使A B 使A B PioglitazonePioglitazo ne Hydrochloride PioglitazonePioglitazo ne Hydrochloride ACTOS 仿112 使PioglitazonePioglitazone HydrochlorideMetformin Sulfonylureainsulin 使使使使使仿仿A B 1 0.00015 仿使仿仿PioglitazonePioglitazone Hydrochloride 使仿A B 使135500 Pioglitazone尿M-M-使63119 使pioglitazone hydrochloride(shelf-life)63119 M-M-(shelf-life)63119 M-M-Pioglitazone使6311 9M-M-63119 M-M-使63119 M-M-仿尿M-M-使63119 M-M-56使M-M-仿M-M-M-M-使18 52 仿M-M-尿M-M- Glitos仿仿仿921 1 WTO 貿Agreement on Trade-Related Aspects of Intellectual Property Rights, TRIPS) 1 3 3 1 4 2 WTO WTO WTO 仿仿使仿 仿仿仿使使使使使使使仿仿使仿仿Copyrightibility仿使使使11955 3 09516001590 951031951031d 仿仿使 仿仿09600252292 201 3 仿仿仿9613209 仿仿201 3 仿仿仿仿仿969 20096032018513仿仿52使使仿仿仿使 201 3 使394 150 1 仿4 3 使394 hierarchy 仿仿仿仿仿仿使仿150 5%使仿仿Glitos仿使135500Pioglitazone Hydrochloride SulfonylureaMetformin insulin 使Glitos 78         97    10    28      2020         97    10    28